Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome

Human Immunology

Volumn 76, Issue 8, 2015, Pages 553-560

  Rajeevan, Mangalathu S ^a   Dimulescu, Irina ^a   Murray, Janna ^a   Falkenberg, Virginia R ^a   Unger, Elizabeth R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Chronic fatigue syndrome; Complement activation; Genetics; Inflammation; Innate immunity

Indexed keywords

COMPLEMENT COMPONENT C2;

ADULT; ALLELE; COMPLICATION; FATIGUE SYNDROME, CHRONIC; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GEORGIA; HEALTH SURVEY; HUMAN; IMMUNITY; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; COMPLEMENT C2; FATIGUE SYNDROME, CHRONIC; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GEORGIA; HUMANS; IMMUNITY; INFLAMMATION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RISK FACTORS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84946759031     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.06.014     Document Type: Article

References (48)

1. Arnett S.V., Alleva L.M., Korossy-Horwood R., Clark I.A. Chronic fatigue syndrome - a neuroimmunological model. Med. Hypotheses 2011, 77:77-83.
2. Arnett S.V., Clark I.A. Inflammatory fatigue and sickness behaviour - lessons for the diagnosis and management of chronic fatigue syndrome. J. Affect. Disord. 2012, 14:130-142.
3. Bansal A.S., Bradley A.S., Bishop K.N., Kiani-Alikhan S., Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav. Immun. 2012, 26:24-31.
4. Bower J.E. Fatigue, brain, behavior, and immunity: summary of the 2012 Named Series on fatigue. Brain Behav. Immun. 2012, 26:1220-1223.
5. Brenu E.W., Huth T.K., Hardcastle S.L., Fuller K., Kaur M., Johnston S., et al. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int. Immunol. 2014, 26:233-242.
6. Devanur L.D., Kerr J.R. Chronic fatigue syndrome. J. Clin. Virol. 2006, 37:139-150.
7. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 2009, 8:287-291.
8. Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr. Opin. Psychiatry 2009, 22:75-83.
9. Broderick G., Ben-Hamo R., Vashishtha S., Efroni S., Nathanson L., Barnes Z., et al. Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis. Brain Behav. Immun. 2013, 28:159-169.
10. Gorelick P.B. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci. 2010, 1207:155-162.
11. Jackson M.L., Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review. J. Clin. Sleep Med. 2012, 8:719-728.
12. Papaioannou V., Pneumatikos I., Maglaveras N. Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: current strengths and limitations. Front. Physiol. 2013, 4:174.
13. Raison C.L., Lin J.M., Reeves W.C. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav. Immun. 2009, 23:327-337.
14. Sorensen B., Streib J.E., Strand M., Make B., Giclas P.C., Fleshner M., et al. Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 2003, 112:397-403.
15. Sorensen B., Jones J.F., Vernon S.D., Rajeevan M.S. Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome. Mol. Med. 2009, 15:34-42.
16. Thomas K.S., Motivala S., Olmstead R., Irwin M.R. Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav. Immun. 2011, 25:53-58.
17. van de Weert-van Leeuwen P.B., Arets H.G., van der Ent C.K., Beekman J.M. Infection, inflammation and exercise in cystic fibrosis. Respir. Res. 2013, 14:32.
18. Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., et al. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Transl. Med. 2011, 9:81.
19. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 2010, 24:1209-1217.
20. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7:96.
21. Klimas N.G., Broderick G., Fletcher M.A. Biomarkers for chronic fatigue. Brain Behav. Immun. 2012, 26:1202-1210.
22. Stringer E.A., Baker K.S., Carroll I.R., Montoya J.G., Chu L., Maecker H.T., et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J. Transl. Med. 2013, 11:93.
23. Carlo-Stella N., Badulli C., De S.A., Bazzichi L., Martinetti M., Lorusso L., et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin. Exp. Rheumatol. 2006, 24:179-182.
24. Landmark-Hoyvik H., Reinertsen K.V., Loge J.H., Kristensen V.N., Dumeaux V., Fossa S.D., et al. The genetics and epigenetics of fatigue. PM R 2010, 2:456-465.
25. Metzger K., Fremont M., Roelant C., De M.K. Lower frequency of IL-17F sequence variant (His161Arg) in chronic fatigue syndrome patients. Biochem. Biophys. Res. Commun. 2008, 376:231-233.
26. Loza M.J., McCall C.E., Li L., Isaacs W.B., Xu J., Chang B.L. Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS ONE 2007, 2(10):e1035.
27. Reeves W.C., Jones J.F., Maloney E., Heim C., Hoaglin D.C., Boneva R.S., et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul. Health Metr. 2007, 5:5.
28. Hardenbol P., Yu F., Belmont J., Mackenzie J., Bruckner C., Brundage T., et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res. 2005, 15:269-275.
29. Karlin-Neumann G., Sedova M., Falkowski M., Wang Z., Lin S., Jain M. Application of quantum dots to multicolor microarray experiments: four-color genotyping. Methods Mol. Biol. 2007, 374:239-251.
30. Saccone SF, Bolze R, Thomas P, Quan J, Mehta G, Deelman E, et al. SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study, Nucleic Acids Res. 38 (Web Server issue) (2010) W201-W209.
31. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies, Nucleic Acids Res. 37 (Web Server issue) (2009) W600-W605.
32. Wagner D., Nisenbaum R., Heim C., Jones J.F., Unger E.R., Reeves W.C. Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul. Health Metr. 2005, 3:8.
33. Geller R.D., Giclas P.C. Chronic fatigue syndrome and complement activation. BMJ Case Rep. 2009, 2009. bcr08.2008.0819.
34. Schutzer S.E., Angel T.E., Liu T., Schepmoes A.A., Clauss T.R., Adkins J.N., et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE 2011, 6:e17287.
35. Markiewski M.M., Lambris J.D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 2007, 171:715-727.
36. Lolis E., Bucala R. Therapeutic approaches to innate immunity: severe sepsis and septic shock. Nat. Rev. Drug Discov. 2003, 2:635-645.
37. Ding X., Patel M., Chan C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 2009, 28:1-18.
38. Despriet D.D., Klaver C.C., Witteman J.C., Bergen A.A., Kardys I., de Maat M.P., et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006, 296:301-309.
39. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
40. Smailhodzic D., Klaver C.C., Klevering B.J., Boon C.J., Groenewoud J.M., Kirchhof B., et al. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology 2012, 119:339-346.
41. Ishida T., Ueda R. Immunopathogenesis of lymphoma: focus on CCR4. Cancer Sci. 2011, 102:44-50.
42. Ge B., Gurd S., Gaudin T., Dore C., Lepage P., Harmsen E., et al. Survey of allelic expression using EST mining. Genome Res. 2005, 15:1584-1591.
43. Bossu P., Ciaramella A., Salani F., Vanni D., Palladino I., Caltagirone C., et al. Interleukin-18, from neuroinflammation to Alzheimer's disease. Curr. Pharm. Des. 2010, 16:4213-4224.
44. Chattergoon M.A., Levine J.S., Latanich R., Osburn W.O., Thomas D.L., Cox A.L. High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection. J. Infect. Dis. 2011, 204:1730-1740.
45. Gregg C., Zhang J., Butler J.E., Haig D., Dulac C. Sex-specific parent-of-origin allelic expression in the mouse brain. Science 2010, 329:682-685.
46. Torpy D.J., Bachmann A.W., Gartside M., Grice J.E., Harris J.M., Clifton P., et al. Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr. Res. 2004, 30:417-429.
47. Verploegen S., Ulfman L., van Deutekom H.W., van A.C., Honing H., Lammers J.W., et al. Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function. Blood 2005, 106:1076-1083.
48. Hong E.P., Park J.W. Sample size and statistical power calculation in genetic association studies. Genomics Inform 2012, 10:117-122.